Subtype
Primary Brain Neoplasm
CI-CAN-00003725Explore in graph →
Non-malignant157 active trials34 evidence items
- NCIt
- C170814
Loading cancer entity…
Subtype
CI-CAN-00003725Explore in graph →
Clinical trials
509 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04051047 | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma | withdrawn | Early Phase 1 | 0 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT02976441 | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas | withdrawn | Early Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Feb 20, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Nov 27, 2019source: clinicaltrials